BFG
REGN icon

Bouchey Financial Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Bouchey Financial Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$224K Hold
359
– – 0.01% 176
2026
Q1 		$276K Buy
359
+29
+9% +$22.2K 0.02% 139
2025
Q4 		$255K Buy
+330
New +$224K 0.02% 139

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Bouchey Financial Group's REGN Position: Q2 2026 in Review

Bouchey Financial Group held its Regeneron Pharmaceuticals (REGN) position steady in Q2 2026 at 359 shares worth $224K. The position accounts for 0.01% of the portfolio, ranked #176.

Bouchey Financial Group first reported a position in REGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $276K in Q1 2026. 373 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Bouchey Financial Group held 359 shares of Regeneron Pharmaceuticals worth $224K as of Q2 2026.
  • Bouchey Financial Group left its Regeneron Pharmaceuticals share count unchanged in Q2 2026.
  • Regeneron Pharmaceuticals made up 0.01% of Bouchey Financial Group's portfolio in Q2 2026, its #176 holding.
  • Bouchey Financial Group first reported a position in Regeneron Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Bouchey Financial Group's Regeneron Pharmaceuticals position peaked at $276K in Q1 2026.
  • 373 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Bouchey Financial Group's 13F filing for Q2 2026, filed 27 Jul 2026.